Exalpha Biologicals, Inc.

Accelerating the Pace of Discovery
Exalpha Biologicals, Inc.

M13 Bacteriophage (g8p)

  • Product Code: X1599M
  • Size: 100 µg
  • Price (USD): $294

Cat #

X1599M		 Quantity:      

Data Sheet

Product Name

M13 Bacteriophage (g8p)

Host/Source

Mouse

Clone

RL-ph2

Isotype

IgG2a

Product Type

Monoclonal Antibody

Reactivity

Ubiquitous

Applications

Western Blot, ELISA, Immunohistochemistry (Frozen Sections), Flow Cytometry, Immunoprecipitation

Size

100 µg

Price (USD)

$294

Background

The display of repertoires of antibody fragments on the surface of filamentous phage offers a new way to produce immunoreagents with defined specificities. Phage derived antibody fragments offer a number of advantages over mouse monoclonal antibodies, such as better clearance from the blood, the possibility to select from human combinatorial libraries and the relative ease by which such fragments can be manipulated. The phage display technique thus facilitates the selection of antibody fragments of therapeutic value or research interest. Antibodies to M13 filamentous phage coat proteins are instrumental in the selection and detection of phages expressing specific antibody fragments or peptide sequences at their surface.

Immunogen

Hybridoma produced by the fusion of splenocytes from BALB/c mice immunized with isolated M13 phage coat proteins and mouse SP2/0-Ag14 myeloma cells.

Positive Control

M13 bacteriophage.

Formulation

Provided as solution in phosphate buffered saline with 0.09% sodium azide

Customer Storage

Product should be stored at -20ºC. Aliquot to avoid freeze/thaw cycles

Product Image

Image Legend

Western blot using anti-M13, g8p (Cat. No. X1599M) on M13 bacteriophage.

Database Links:

SwissProtP69541M13 Phage

References

1. Meulemans, E. V., et al. 'Phage displayed antibodies specific for a cytoskeletal antigen. Selection by competitive elution with a monoclonal antibody.' Hum Antibodies Hybridomas 1995: 6, 113-118. 2. Meulemans, E. V., et al. 'Selection of phage-displayed antibodies specific for a cytoskeletal antigen by competitive elution with a monoclonal antibody.' J. Mol. Biol. 1994: 244, 353-360.